Guyla Simig

Title: Guyla Simig: Innovator in Pharmaceutical Chemistry

Introduction

Guyla Simig is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug synthesis. His work has led to advancements in the preparation of high-purity compounds that are essential for medical applications.

Latest Patents

Guyla Simig holds a patent for a process related to the preparation of high purity perindopril and intermediates useful in its synthesis. The patent describes a compound of the Formula I, which is a known ACE inhibitor, and outlines a method for producing it free of contaminants derived from dicyclohexyl carbodiimide. This invention also introduces new intermediates of the general Formula III, where R represents lower alkyl or aryl lower alkyl. He has 1 patent to his name.

Career Highlights

Simig is currently associated with Les Laboratoires Servier, a prominent pharmaceutical company. His role involves research and development, focusing on innovative solutions for drug formulation and synthesis. His expertise in the field has positioned him as a valuable asset to his organization.

Collaborations

Throughout his career, Guyla Simig has collaborated with several professionals, including Tibor Mezei and Marta Porcs-Makkay. These collaborations have fostered a productive environment for innovation and have contributed to the success of various projects within the pharmaceutical sector.

Conclusion

Guyla Simig's contributions to pharmaceutical chemistry exemplify the impact of innovation in drug development. His patent for the preparation of high purity perindopril showcases his commitment to advancing medical science. His work continues to influence the field and improve therapeutic options for patients.